Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.69 USD
Change Today -0.075 / -4.26%
Volume 429.6K
TIAN On Other Exchanges
Symbol
Exchange
Shanghai
Singapore
OTC US
Stuttgart
As of 5:04 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

tianjin zhong xin pharm co-s (TIAN) Snapshot

Open
$1.76
Previous Close
$1.76
Day High
$1.77
Day Low
$1.69
52 Week High
05/28/15 - $1.92
52 Week Low
12/22/14 - $0.85
Market Cap
2.7B
Average Volume 10 Days
1.4M
EPS TTM
$0.51
Shares Outstanding
200.0M
EX-Date
05/22/15
P/E TM
20.6x
Dividend
$0.15
Dividend Yield
1.91%
Current Stock Chart for TIANJIN ZHONG XIN PHARM CO-S (TIAN)

Related News

No related news articles were found.

tianjin zhong xin pharm co-s (TIAN) Related Businessweek News

No Related Businessweek News Found

tianjin zhong xin pharm co-s (TIAN) Details

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, an investment holding company, produces and sells traditional Chinese medicines, western medicines, and healthcare products primarily in the People's Republic of China. It offers Chinese patent medicines, Chinese medicinal materials, pharmaceutical raw materials and western medicines, bioengineering drugs, nutritious and health products, etc. The company’s principal products include Suxiao Jiuxin Wan, Huoxiang Zhengqi Ruan Jiaonang, Zilong Jin Pian, Jinqi Jiangtang Pian, Weichang An Wan, Biqi Jiaonang, a-2b Interferon, Gliclazide, Te Zi She Fu, etc. It is also involved in the wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products. In addition, the company sells medicinal products under its own brand and other brands to wholesalers. Tianjin Zhong Xin Pharmaceutical Group Corporation Limited was founded in 1992 and is based in Tianjin, the People's Republic of China.

Founded in 1992

tianjin zhong xin pharm co-s (TIAN) Top Compensated Officers

Executive Chairman, General Manager and Chair...
Total Annual Compensation: CNY1.0M
Executive Director
Total Annual Compensation: CNY757.3K
Chief Engineer, Deputy General Manager, Execu...
Total Annual Compensation: CNY500.0K
Compensation as of Fiscal Year 2013.

tianjin zhong xin pharm co-s (TIAN) Key Developments

Tianjin Zhongxin Pharmaceutical Group Corporation Limited Announces Dividend for 2014, Payable on June 1, 2015

Tianjin Zhongxin Pharmaceutical Group Corporation Limited announced taxes included cash dividend of RMB 1.5 for every 10 shares, payable on June 1, 2015, for 2014. The record date is May 29, 2015, and ex-dividend date is June 1, 2015.

Tianjin Zhongxin Pharmaceutical Group Corporation Limited Announces Final Dividend for the Year Ended December 31, 2014, Payable on or About June 12, 2015

Tianjin Zhongxin Pharmaceutical Group Corporation Limited announced final dividend of RMB 15 cents per ordinary Share for the year ended December 31, 2014. The final dividend, which was approved by shareholders of the company at the company's annual general meeting held on 15 May 2015. Shareholders whose securities accounts with The Central Depository (Pte) Limited are credited with Shares as at 5.00 p.m. on 26 May 2015 will be entitled to the Final Dividend. The Final Dividend is expected to be paid on or about 12 June 2015.

Tianjin Zhong Xin Pharm Group Announces Appointment of Mr. Wang Lei as Executive Director

On May 15, 2015, Tianjin Zhong Xin Pharm Group announced the appointment of Mr. Wang Lei as executive director of the company, he will be a member of audit committee and the strategy committee and the chairman of the nomination committee. For the period from March 2001 to April 2004 she was firstly appointed as deputy director of planning division and then as the deputy director of industry department in the company. From June 2014 to present, she is working as the deputy general manager of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TIAN:SP $1.69 USD -0.075

TIAN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
American Oriental Bioengineering Inc $3.85 USD 0.00
View Industry Companies
 

Industry Analysis

TIAN

Industry Average

Valuation TIAN Industry Range
Price/Earnings 56.5x
Price/Sales 2.9x
Price/Book 7.2x
Price/Cash Flow 40.7x
TEV/Sales 2.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANJIN ZHONG XIN PHARM CO-S, please visit www.zhongxinp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.